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PURPOSE. Previous studies have demonstrated that melatonin has an important role in the
modulation of photoreceptor viability during aging and may be involved in the pathogenesis
of age-related macular degeneration.This hormone exerts its influence by binding to G-protein
coupled receptors named melatonin receptor 1 (MT1) and 2 (MT2). Melatonin receptors 1 and
2 activate a wide variety of signaling pathways.
METHODS. Melatonin-proficient mice (C3H/fþ/þ) and melatonin-proficient mice lacking MT1 or
MT2 receptors (MT1
/ and MT2/) were used in this study. Mice were killed at the ages of 3
and 18 months, and photoreceptor viability was determined by counting nuclei number in
the outer nuclear layer (ONL). Cones were identified by immunohistochemistry using peanut
agglutinin (PNA) and green/red and blue opsin antibodies. Protein kinase B (AKT) and
forkhead box O (FOXO1) were assessed by Western blotting and immunohistochemistry.
RESULTS. Thenumber of nuclei in theONLwas significantly reduced inC3Hfþ/þ,MT1/, andMT2
/ mice at 18 months of age with respect to 3-month-old animals. In 18-month-old MT1/ and
MT2
/mice, but not in C3H/fþ/þ, the number of coneswas significantly reducedwith respect to
young MT1
/ and MT2/ mice or age-matched C3H/fþ/þ. In C3H/fþ/þ, activation of the AKT-
FOXO1 pathway in the photoreceptors showed a significant difference between night and day.
CONCLUSIONS. Our data indicate that disruption of MT1/MT2 heteromer signaling induces a
reduction in the number of photoreceptors during aging and also suggest that the AKT-
FOXO1 survival pathway may be involved in the mechanism by which melatonin protects
photoreceptors.
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Retinal melatonin is synthesized by photoreceptors of manyvertebrate species via a well-defined biosynthetic path-
way.1,2 The amount of melatonin produced by the retina is
much smaller than that produced by the pineal gland, and
retinal melatonin is thought to act as a local neuromodulator
within the eye.3 Melatonin synthesis in the retina, as in the
pineal gland, occurs primarily during the night in darkness,
and, thus, melatonin levels are high during the night and low
during the day.4 Melatonin synthesis is controlled by a circadian
clock located within the photoreceptors.5–8 Transcriptional
and posttranslational mechanisms ensure that melatonin levels
are maintained at extremely low levels in the presence of
light.9,10 Such tight control of retinal melatonin levels suggests
that high melatonin levels during the light-phase may be
deleterious for the photoreceptor cells.11
Melatonin exerts its influence by binding to G protein-
coupled receptors (GPCRs) named melatonin receptor type 1
(MT1) and type 2 (MT2). Both receptors are present in the
vertebrate retina and activate a wide variety of signaling
pathways.12–15 In the photoreceptors MT1 and MT2 form
heteromeric complexes, as demonstrated previously in vi-
tro16,17 and recently confirmed in vivo.12
Melatonin modulates the sensitivity of photoreceptors and
second-order neurons at night when photopic input is low.18 In
some species, melatonin can affect glutamatergic transmission
from cones to cone-driven bipolar cells19 and may potentiate
responses of ON bipolar cells to rod signals.20 In Xenopus
laevis, melatonin directly stimulates the responsiveness of rod
photoreceptors.21 Administration of exogenous melatonin in
fishes and amphibians can increase the amplitude of the a- and
b-wave of the scotopic electroretinogram.20,21 In mice,
administration of exogenous melatonin increases the ampli-
tudes of a- and b- waves and lowers the scotopic threshold
response (i.e., visual sensitivity) to levels observed at night
under controlled conditions; removal of MT1 and/or MT2
receptors abolishes these effects.12,22 Finally, several studies
have shown that melatonin has a key role in the regulation of
retinal circadian rhythms.23,24
Earlier studies also have demonstrated that melatonin can
exert beneficial and detrimental effects on photoreceptors: on
one hand it may have an important role in protecting them
from oxidative stress,25 preventing apoptosis26 and promotes
photoreceptor viability during aging.22 On the other hand, it
also can sensitize photoreceptors to light-induced damage.27 A
few studies also have implicated melatonin in the pathogenesis
of age-related macular degeneration (ARMD). Age-related
macular degeneration is a slow and progressive disease of the
macula, that is, the central part of the retina where cone
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density is maximal, and constitutes the leading cause of
irreversible visual loss in the Western world.28 Yi et al.29
reported that daily administration of melatonin (3 mg) may
protect the retina and delay the progression of ARMD, while
Rosen et al.30 described that production of melatonin is
decreased in ARMD patients with respect to age-matched
controls. These findings suggest that a deficiency in melatonin
may have a role in the progression of ARMD.
To gather more insight into the role of melatonin during
aging, we investigated the effect of MT1 and MT2 deletion on
the viability of cone photoreceptors and the potential role of
melatonin receptors signaling on the survival pathway involv-
ing a serine/threonine protein kinase (AKT) and the Forkhead-
related family of mammalian transcription factor (FOXO1).31
MATERIALS AND METHODS
Animals
We used C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice
in this study.12,22 All the experimental procedures were done
in accordance with the Association for Assessment of
Laboratory Animal Care policies and approved by the More-
house School of Medicine Animal Care and Use Committee and
in accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research.
Outer Nuclear Layer Cell Counting
Photoreceptor nuclei in the ONL were counted in a 10-lm
microscopic field that was centered at 300 lm above the edge of
the optic nerve head. For each sample, we counted the number
of photoreceptor cells in 10 different locations within each of 3
adjacent sections (see the study of Baba et al.22 for further details).
Immunohistochemical Analysis of
Phosphorylated-AKT, Phosphorylated-FOXO1, and
FOXO1
After euthanasia, eyes were collected and fixed with 4%
paraformaldehyde (PAF) in PBS for 12 hours. Subsequent to
fixation, the eyeballs were rinsed in PBS, transferred to sucrose
30% overnight, and embedded (Tissue-Tek CRYO-OCT Com-
pound; Fisher Healthcare, Pittsburgh, PA, USA). Cryostat
sections (12 lm thick) were mounted on SuperFrost*Plus
slides (VWR, Atlanta, GA, USA). The retinas sections were
permeabilized with 0.1% Triton X-100 for 5 minutes and the
endogenous peroxidase activity was quenched with PBSþ 1%
H202 during 1 hour. Sections then were incubated in blocking
buffer 1 hour (1% BSA in PBS) and in primary antibody
overnight at 48C. The primary antibodies were as follows:
monoclonal anti-rabbit phosphorylated (P) AKT (Ser473,
#4060; Cell Signaling, Boston, MA, USA), dilution 1:200;
polyclonal anti-rabbit P-FOXO1 (Ser256, #9461; Cell Signaling),
1:500; monoclonal anti-rabbit FOXO1 (detects P and unphos-
phorylated [UnP] FOXO1; #2880; Cell Signaling), 1:200. After
extensive wash in PBS, retinas were incubated 1 hour in HRP
conjugated secondary antibody (Tyramide Signal Amplification
Kit #12; Molecular Probes, Life Technologies, Carlsbad, CA,
USA), dilution 1:100. Retinal sections again were washed
thoroughly and incubated 10 minutes with labeled tyramide
(Tyramide Signal Amplification Kit #12; Molecular Probes, Life
Technologies), dilution 1:100. After several washes, retinal
sections were mounted with mounting medium (Prolong;
Molecular Probes, Life Technologies) before being examined
with a confocal microscope (Zeiss LSM700).
Immunofluorescence Analysis of AKT, Red/Green
Opsin, Blue Opsin, and Peanut Agglutinin
The samples were treated as described previously. For AKT
immunostaining, after fixation, the eyecups were incubated in
a retrieval solution (10 mM sodium citrate, pH6) overnight at
48C. The eyes were immersed in boiling retrieval solution 3
minutes and immediately placed in cold sucrose 30%.
The sections were permeabilized with Triton X-100 (0.1% in
PBS) for 5 minutes and then saturated with blocking buffer (3%
BSA, 0.05% Tween-20, 0.1% Triton X-100, 0.1% sodium azide in
PBS) during 2 hours. Sections were incubated 2 hours with
rhodamine-labeled peanut agglutinin (PNA, RL-1072; Vector
Laboratories, Burlingame, CA, USA), dilution 1:500; or over-
night with primary antibody diluted in blocking buffer:
polyclonal anti-rabbit red/green opsin (medium/long-wave-
length opsin, AB5405; Chemicon International, Millipore,
Billerica, MA, USA), 1:1000; polyclonal anti-rabbit blue opsin
(short-wavelength opsin, AB5407; Chemicon International,
FIGURE 1. Melatonin receptor 1 and MT2 deletion reduce photoreceptor viability during aging. Number of cell nuclei in the ONL of C3H/fþ/þ,
C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice at 3 (A) and 18 months (B) of age in the central retina. A significant change in the ONL cell number
occurs between C3H/fþ/þMT1/, C3H/fþ/þMT2/, and C3H/fþ/þ at 18 months of age (*P < 0.05). The number of cells in each genotype also is
affected by aging (#P < 0.05). Error bars: Mean 6 SEM; n¼ 4 to 6. #P < 0.05, 1-way ANOVA, followed by Holm-Sidak test. WT, C3H/fþ/þ; MT1/,
C3H/fþ/þMT1/; MT2/, C3H/fþ/þMT2/.
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FIGURE 2. Melatonin receptor 1 and MT2 deletion reduce cones viability during aging. Peanut agglutinin immunoreactivity in the central retina of
C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice at 3 months (A) and 18 months of age (B). Quantification of PNA-labeled cones at the
photoreceptor OS level of C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice retina at 3 months (C) and 18 months of age (D). A significant
change in the number of PNA-positive cells is observed between C3H/fþ/þ and C3H/fþ/þMT1/, C3H/fþ/þMT2/ at 18 months. Red/green cone (red/
green opsin) localization in the central retina of 3 months (E) and 18 months (F) C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice.
Quantification of red/green cone-positive cells in C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/mice retina at 3 months (G) and 18 months of age
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Millipore), 1:500; monoclonal anti-mouse AKTpan (detects P
and UnP AKT, #2920; Cell Signaling), 1:50. Secondary antibody
incubation was performed at room temperature for 2 hours
with Alexa488 conjugated goat anti-rabbit or Alexa568
conjugated goat anti-mouse (Molecular Probes, Thermo Fisher,
Rockford, IL, USA), dilution 1:500. Retinas were washed
thoroughly, mounted with Prolong medium (Prolong, Molec-
ular Probes, Life Technologies) and observed with a confocal
microscope (Zeiss LSM700).
Pictures were obtained of the central, middle, and
peripheral sections of the retina (six regions in total). The
number of cones was counted at the level of cone outer
(H). A significant change in the number of red/green cones occurs between 18 months old C3H/fþ/þ and C3H/fþ/þMT1/, C3H/fþ/þMT2/ mice.
Blue cones (blue opsin) immunoreactivity in the central retina of C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice at 3 months (I) and 18
months of age (J). Quantification of blue cone–positive cells in the retina of the three genotypes of mice at 3 months (K) and 18 months of age (L).
The number of blue cones does not change between 18 months old C3H/fþ/þ and C3H/fþ/þMT1/, C3H/fþ/þMT2/mice. Error bars: Mean 6 SEM;
n¼ 3 to 4. P < 0.05, 1-way ANOVA, Holm-Sidak test. Scale bar: 20 lm.
FIGURE 3. Melatonin receptor 1 and MT2 deletion effects of P-AKT/AKT levels. Western blotting analysis of P-AKT and AKT (P and UnP) levels in
retinas at different Zeitgeber Time (ZT) in 3 months C3H/fþ/þ (A, D, G, J), C3H/fþ/þMT1/ (B, E, H, K), and C3H/fþ/þMT2/mice (C, F, I, L). P-AKT
(Thr308 and Ser473) levels were significantly higher in the late night (ZT19-22; P < 0.05, 1-way ANOVA, followed by Tukey test) in C3H/fþ/þ but not in
C3H/fþ/þMT1/ and C3H/fþ/þMT2/ mice. Densitometric quantification of P-AKT (Thr308 and Ser473) and AKT levels were performed on three
independent retinal samples for each ZT. AKT: serine/threonine protein kinase.
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segment (OS) in a 140 lm length area for each region of the
retina. The number of cones in the retina represents the
average of the six values and was determined for each animal.
Western Blotting
Retinas were sonicated in cell extraction buffer (Novex;
Invitrogen, Camarillo, CA, USA) and briefly centrifuged. The
protein content of the supernatants were determined by Micro
BCA Protein Assay Kit (Thermo Fisher Scientific Scientific).
Proteins (10 lg/lane) were separated according to the method
of Laemmli and transferred to Immobilon-P transfer membrane
(Millipore). Membranes were briefly washed with Tris-buffered
saline (20 mM Tris-HCl, pH 7.6; 150 mM NaCl) containing 0.1%
Tween20 (TBS-Tween). Then membranes were blocked for 1
hour in TBS-Tween containing 5% nonfat milk powder or BSA
at room temperature. Membranes were washed with TBS-
Tween, and then incubated 16 hours at 48C with primary
antibodies: P-AKT (Ser473), P-AKT (Thr308, #2965; Cell
Signaling), AKTpan, P-FOXO1 (Ser256), FOXO1, diluted
1:5000-1:80000 in TBS-Tween containing 1 % nonfat milk or
BSA. Membranes then were washed four times for 10 minutes
with TBS-Tween previous incubation with HRP conjugated
donkey anti-rabbit IgG or anti-mouse IgG diluted 1:1000 to
1:5000 (Cell Signaling) in TBS-Tween containing 1% nonfat
milk. Membranes finally were washed 4 times for 10 minutes
with TBS-Tween. Super Signal West FemtoChemiluminescent
Substrate (Thermo Fisher Scientific) was used to detect the
antigen.
Statistical Analysis
Data are given as the mean 6 SEM of n ¼ 3 to 6 animals.
Statistical analysis was performed with 1-way ANOVA using the
Sigma plot software. The significant level was set at P < 0.05.
For cell counting, ANOVA were followed by post hoc Holm-
Sidak test. For Western blotting, ANOVA were followed by the
post hoc Tukey test.
RESULTS
Effect of MT1 and MT2 Deletion on Photoreceptor
Cell Viability During Aging
No significant differences were observed among young (3
months of age) C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/
mice (P > 0.05, 1-way ANOVA; Fig. 1A), whereas in older C3H/
TABLE. MT1 and MT2 Deletion Reduce Cone Cell Viability During Aging
Genotype Age
PNA MWS-Opsin SWS-Opsin
Peripheral Middle Central Peripheral Middle Central Peripheral Middle Central
WT 3 7.56 6 0.40 9.56 6 0.32 10.79 6 0.16 4.38 6 0.25 4.83 6 0.08 5 6 0.31 1.58 6 0.79 2.08 6 0.79 2.75 6 0.50
18 7.80 6 0.87 9.11 6 0.52 10.21 6 0.65 4.50 6 0.31 5.92 6 0.40 5.25 6 0.40 2.63 6 0.76 2.67 6 0.87 3.04 6 0.96
MT1
/ 3 7.56 6 0.15 9.28 6 0.33 10.75 6 0.65 3.53 6 0.16 4.81 6 0.34 5.34 6 0.69 1.59 6 0.24 2.47 6 0.42 3.13 6 1.04
18 4.56 6 0.50* 6.34 6 0.47* 7.66 6 0.58* 3.25 6 0.39 3.97 6 0.51* 4.41 6 0.19 1.41 6 0.39 1.44 6 0.60 2.19 6 0.92
MT2
/ 3 7.06 6 0.44 9.75 6 0.63 10.75 6 0.42 3.69 6 0.32 5.25 6 0.27 5.22 6 0.37 1.75 6 0.47 3.03 6 1.00 3.28 6 1.01
18 5.31 6 0.40* 6.88 6 0.67 7.47 6 0.24* 2.53 6 0.32* 4.34 6 0.16* 4.34 6 0.37 1.84 6 0.22 2.41 6 0.14 3.22 6 0.27
Number of PNA, red/green opsin, blue opsin–positive cells in the central, middle, and peripheral retina of C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/
fþ/þMT2/ mice at 3 and 18 months of age. Abbreviations as in Figure 1. Mean 6 SEM; n ¼ 3 to 4.
* P < 0.05 (1-way ANOVA, Holm-Sidak test) indicates a significant difference between the same genotypes at the two different ages.
FIGURE 4. Melatonin receptor 1 and MT2 deletion affects the of P-FOXO1/FOXO1 levels. Western blotting analysis of P-FOXO1 and FOXO1 levels (P
and UnP) in retinas at different Zeitgeber Time (ZT) in 3-month-old C3H/fþ/þ (A, D), C3H/fþ/þMT1/ (B, E), and C3H/fþ/þMT2/ mice (C, F). P-
FOXO1 levels were significantly higher in the late night in C3H/fþ/þ (ZT19-22, P < 0.05, 1-way ANOVA, followed by Tukey test) but not in C3H/fþ/
þMT1/ and C3H/fþ/þMT2/ mice. Densitometric quantification of P-FOXO1 and FOXO1 levels were performed on three independent retinal
samples for each ZT. FOXO1: Forkhead-related family of mammalian transcription factor 1.
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fþ/þMT1/, and C3H/fþ/þMT2/ mice (18 months of age) we
observed a significant reduction in the number of photorecep-
tors with respect to C3H/fþ/þ at the same age (P < 0.05, 1-way
ANOVA, Holm-Sidak test; Fig. 1B). We also observed a small,
but significant, reduction in the number of photoreceptor
nuclei in the ONL of older C3H/fþ/þ (18 months) with respect
to the number of cells of young C3H/fþ/þ (3 months, P < 0.05,
1-way ANOVA, Holm-Sidak test; Figs. 1A, 1B).
Retinal sections obtained from C3H/fþ/þ, C3H/fþ/þMT1/,
and C3H/fþ/þMT2/mice at 3 and 18 months of age (Figs. 2A,
2B) were labeled with PNA to identify cones. No differences
were observed in 3-month-old mice of the different genotypes
(P > 0.05, 1-way ANOVA; Fig. 2C), whereas at 18 months,
C3H/fþ/þMT1/ and C3H/fþ/þMT2/mice showed a significant
decrease (approximately 30%) in the number of PNA-labeled
cones in the retina with respect to C3H/fþ/þ at the same age (P
< 0.05, 1-way ANOVA, Holm-Sidak test; Fig. 2D). Each region
of the retina (peripheral, middle, central) exhibited a
significant decrease in the number of PNA-positive cells for
C3H/fþ/þMT1/ mice (P < 0.05, 1-way ANOVA, Holm-Sidak
test; see Table), while only peripheral and central retina of
C3H/fþ/þMT2/ mice showed significant decreases (P < 0.05,
FIGURE 5. P-AKT is localized within photoreceptors and the GCL. P-AKT localization by fluorescence immunohistochemistry on the retina sections
of 3 months old C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/mice at ZT22 and ZT1. At ZT22 (nighttime), P-AKT staining is intense in OS and GCL
of C3H/fþ/þmice (A). P-AKT staining is moderate in OS and GCL of C3H/fþ/þMT1/ and C3H/fþ/þMT2/mice, respectively (C, E). Enlargement of
boxed area of C3H/fþ/þmice at ZT22 (A’). Staining is present in one specific structure in OS (arrowhead, [A’]). Enlargement of boxed area of C3H/
fþ/þMT1/ and C3H/fþ/þMT2/mice retinas, respectively, confirm P-AKT expression in OS (C’, E’). At ZT1, P-AKT staining is low in OS and GCL of
C3H/fþ/þ (B). P-AKT staining is present in OS and GCL of C3H/fþ/þMT1/ and C3H/fþ/þMT2/mice, respectively (D, F). Enlargement of boxed area
of C3H/fþ/þ mice retinas at ZT1 confirm low P-AKT staining in OS (B’). Enlargement of boxed area of C3H/fþ/þMT1/ and C3H/fþ/þMT2/ mice
retinas, respectively, show moderate staining in OS (D’, F’). Control without primary antibody (G). Scale bars: 50 lm (A–G), 20 lm (A’–F’).
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1-way ANOVA, Holm-Sidak test; see Table). To explore possible
differences in cone subpopulations, we labeled red/green
(medium/long wavelength opsin, Figs. 2E, 2F) and blue cones
(short wavelength opsin, Figs. 2I, 2J) with specific antibodies.
No significant differences were observed between the three
genotypes at 3 months of age for either red/green (P > 0.05, 1-
way ANOVA; Fig. 2G) or blue cones (P > 0.05, 1-way ANOVA;
Fig. 2K). On the other hand, there was a significant reduction
(27%–30%) in the number of red/green cones in the entire
retina of C3H/fþ/þMT1/ and C3H/fþ/þMT2/ mice with
respect to C3H/fþ/þat the same age (P < 0.05, 1-way ANOVA,
Holm-Sidak test; Fig. 2H). As shown in the Table, there was a
significant reduction in the number of red/green cones in the
middle retina of C3H/fþ/þMT1/ and C3H/fþ/þMT2/ mice,
and in the peripheral retina of C3H/fþ/þMT2/mice (P < 0.05,
1-way ANOVA, Holm-Sidak test; see Table). The number of blue
cones was not different among the different parts of the retina,
for all genotypes and ages (P > 0.05, 1-way ANOVA; Fig. 2L,
see Table).
Effect of MT1 and MT2 Deletion on the AKT-FOXO1
Pathway
To investigate the signaling pathway by which melatonin may
affect cone viability, we determined the levels of P-AKTSer473/
AKT and P-AKTThr308/AKT in the retina of C3H/f
þ/þ, C3H/
fþ/þMT1/, and C3H/fþ/þMT2/ mice over 24 hours. In C3H/
fþ/þmice, P-AKTSer473/AKT levels showed significant changes
during the light/dark cycle (P < 0.01, 1-way ANOVA, Tukey
test) with a peak at ZT22 (Fig. 3D). P-AKTThr308/AKT
exhibited similar profile over 24 hours (P < 0.05, 1-way
ANOVA, Tukey test, Fig. 3J). In C3H/fþ/þMT1/ and
C3H/fþ/þMT2/ mice, P-AKTSer473/AKT (Figs. 3E, 3F) and P-
AKTThr308/AKT (Figs. 3K, 3L) levels were not significantly
different during the 24-hour period (P > 0.05 in each case, 1-
way ANOVA). We also assayed the P-FOXO1/FOXO1 levels in
the retina of the three genotypes (Fig. 4). Once more, the
levels of P-FOXO1/FOXO1 exhibited a significant change in
the retina of C3H/fþ/þ over 24 hours with a peak at ZT22 (P <
0.05 1-way ANOVA, Tukey test; Fig. 4D). No changes in P-
FOXO1/FOXO1 level were observed over the 24 hours in the
retinas of C3H/fþ/þMT1/ and C3H/fþ/þMT2/mice (P > 0.05
in both case, 1-way ANOVA; Figs. 4E, 4F).
Localization of AKT and FOXO1 in Photoreceptors
To localize AKT in the retina of C3H/fþ/þ, C3H/fþ/þMT1/, and
C3H/fþ/þMT2/ mice we performed immunohistochemistry
using antibodies against AKT and P-AKTSer473, at ZT22 (when
the level of P-AKT is highest in C3H/fþ/þmice; Figs. 3D, 3J) and
ZT1 (when the level of P-AKT is lowest in C3H/fþ/þmice; Figs.
3D, 3J). In C3H/fþ/þ, AKTpan was widespread and immunore-
activity was observed in the OS and inner segment (IS,
Supplementary Figs. S1A, S1A’) as well as in the outer
plexiform layer (OPL), inner plexiform layer (IPL) and ganglion
cell layer (GCL, Supplementary Fig. S1A). At ZT22, P-AKTSer473
immunoreactivity was localized in OS and GCL of C3H/fþ/þ
(Figs. 5A, 5A’), while at ZT1 P-AKTSer473 immunoreactivity was
weaker in these locations (Figs. 5B, 5B’). In C3H/fþ/þMT1/
and C3H/fþ/þMT2/ mice, P-AKTSer473 immunoreactivity was
detected in the OS and in GCL at ZT22 (Figs. 5C, 5E) and at
ZT1 (Figs. 5D, 5F). There were no clear changes in the signal
intensity between the two time points. We then investigated
the cellular localization of P-AKTSer473 in the OS by performing
double immunofluorescence with PNA (Fig. 6A’). In C3H/fþ/þ
mice, P-AKTSer473 immunoreactivity was observed in the OS of
rods and cones (Fig. 6A’’).
At ZT22, FOXO1 immunoreactivity wasweak andwidespread
(Supplementary Fig. S2A). P-FOXO1 immunoreactivity was
localized to the OS, IS and GCL of C3H/fþ/þmice at ZT22 (Fig.
7A). As for P-AKT, P-FOXO1 signal in the OS and IS was stronger
at ZT22 (Fig. 7A’) than at ZT1 (Figs. 7B, 7B’). In C3H/fþ/þMT1/
and C3H/fþ/þMT2/mice, P-FOXO1 was weakly detected in OS
and IS at ZT22 (Figs. 7C, 7E) and ZT1 (Figs. 7D, 7F). The pattern
of P-FOXO1 immunoreactivity in OS and IS was similar (slight
signal and no difference between ZT22 and ZT1; Figs. 7C’, 7D’,
7E’, 7F’) in C3H/fþ/þMT1/ and C3H/fþ/þMT2/ mice. Also in
this case, we performed double immunofluorescence with P-
FOXO1 antibody and PNA. P-FOXO1 staining was stronger in the
cones, but the signal also was present in rods (Fig. 8A’’).
DISCUSSION
The data presented in this study indicated that melatonin
signaling via its G-protein coupled receptors increases
photoreceptor viability during aging. C3H/fþ/þMT1/ and
C3H/fþ/þMT2/ mice lose photoreceptors at 18 months
compared to C3H/fþ/þ mice at the same age (Fig. 1). The
observation that similar results were obtained in C3H/
fþ/þMT1/ and C3H/fþ/þMT2/mice suggests that also in this
case the action of melatonin is mediated by MT1/MT2
heteromers.12 We used PNA marker to determine the effect
of MT1 and MT2 receptor deletion on cone number during
aging. In the mouse, cones represent a small percentage (2%–
3%) of the total number of photoreceptors with the red/green
being the most prevalent type and with a wide distribution
within the retina, while the blue cones are low in number and
with inferior-superior gradient.32–34 Furthermore, it also has
been reported that both opsins are present in the same
cone.32,35 As shown in the Table, we did not detect any
significant changes in the number of PNA-labeled cones in
C3H/fþ/þ mice during aging, whereas removal of melatonin
receptors led to a decrease of PNA-labeled cones during
aging. The decline in the number of red/green cones during
aging is more pronounced in the middle retina of
C3H/fþ/þMT1/ and C3H/fþ/þMT2/ (see Table). However, it
is worth mentioning that in MT2
/ mice we also detected a
significant reduction in the number of red/green cones in the
periphery (see Table). This result is somewhat puzzling, since
we believe that the action of melatonin on the photorecep-
tors is mediated by MT1/MT2 signaling.
12 Further studies will
FIGURE 6. P-AKT is present in rods and cones. Fluorescence
immunohistochemistry of C3H/fþ/þ mice retinal sections at 3 months.
Images were obtained at the level of the photoreceptor OS at ZT22. P-
AKT (green) is seen in one specific structure (A). Cones are stained
with PNA (red) while rods are unstained and visible as dark profiles
(A’). In the merge, P-AKT is present in rod and cones OS (A’’). Scale
bar: 10 lm.
Disruption of Melatonin Receptors Signaling IOVS j January 2016 j Vol. 57 j No. 1 j 100
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/934840/ on 09/27/2017
be needed to determine whether the red/green cones viability
in the periphery are, indeed, negatively affected by MT2
signaling removal or such a result is due to other factors (e.g.,
biological variability and/or counting procedures). We did not
detect a significant change in the number of blue cones in
C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice (see
Table) possibly due to their unequal topography and their
low density across the entire retina.33 In agreement with a
previous study,33 we observed a centro-peripheral density
gradient of PNA, red/green, and blue labeled cones in C3H/
fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice at 3 and 18
months (see Table).
It is worth mentioning that the vast majority of mouse
strains are genetically incapable of synthesizing melatonin.36
Indeed, most of laboratory strains (e.g., C57/BL6, Balb/C,
SV129) are considered melatonin-deficient mice, whereas only
CBA and C3H are considered melatonin-proficient strains.
Interestingly, melatonin-deficient mice strains also show a
significant decrease in cone numbers during aging37,38 further
supporting the notion that melatonin receptors signaling may
be an important signal to promote cones viability during aging.
Previous studies have reported that the number of
photoreceptors decreases during aging and that rods and
cones are both affected.22,37,39,40 However, it is believed that
rods dye first and cones later;39,41 thus, suggesting that rods
may produce a trophic factor necessary for cone survival.42,43
However, the variability in cone survival patterns in different
rod-initiated degenerations suggests this cannot be the only
explanation.44 A more recent work has suggested that the
death of rods leads to development of a hyperoxygenated
FIGURE 7. P-FOXO1 is localized in photoreceptors and the GCL. P-FOXO1 localization by fluorescence immunohistochemistry performed on retinal
sections of 3 months old C3H/fþ/þ, C3H/fþ/þMT1/, and C3H/fþ/þMT2/ mice at ZT22 and ZT1. At ZT22, P-FOXO1 is localized in OS, IS and GCL
(arrowhead) of C3H/fþ/þ (A). Enlargement of boxed area shows the staining mainly in one specific structure in IS and OS (arrowhead, [A’]). At
ZT1, P-FOXO1 is not detected in the retina of C3H/fþ/þ (B). Enlargement of the boxed area confirms no staining detected in OS and IS of C3H/fþ/þ
(B’). P-FOXO1 staining is very weak in OS, IS, and GCL of C3H/fþ/þMT1/ at ZT22 (C) and ZT1 (D) as in OS, IS, and GCL of C3H/fþ/þMT2/mice at
ZT22 (E) and ZT1 (F). Enlargement of boxed area confirms a very low level of P-FOXO1 in OS and IS of C3H/fþ/þMT1/ and C3H/fþ/þMT2/mice
(C’–F’). Control without primary antibody (G). Scale bars: 50 lm (A–F), 20 lm (A’–F’).
Disruption of Melatonin Receptors Signaling IOVS j January 2016 j Vol. 57 j No. 1 j 101
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/934840/ on 09/27/2017
microenvironment that increases oxidative stress and pro-
motes cone death.45 In our study, we detected a reduction in
the number of rods (Fig. 1) and cones (Fig. 2; Table). Since
MT1 and MT2 receptors are localized in both photoreceptor
types,12,46 we believe that rods and cones may be directly
affected by removal of melatonin receptors signaling.
Additional studies are required to determine whether rods
or cones die first in mice lacking melatonin receptors
signaling.
Previous studies also have shown that melatonin may affect
the phosphatidylinositol 3 kinase (PI3K)-AKT pathway.47 AKT
has a critical role in controlling the balance between apoptosis
and cell survival in response to extra- and intracellular
signaling. The principal role of AKT is to facilitate growth
factor-mediated cell survival and to block apoptotic cell death,
which is achieved by phosphorylating and deactivating
proapoptotic factors. Protein kinase B activity is the result of
a balance between two phosphorylation sites on Thr308 and
Ser473.48 Several studies have shown that AKT can directly
phosphorylate FOXO, thus promoting cell survival.31 When
AKT is inactive, FOXOs are localized within the nucleus where
it induces the expression of FasL mRNA.49 On the contrary,
when AKT is activated, it phosphorylates FOXOs. FOXOs then
are translocated from the nucleus to the cytoplasm, thus
inhibiting the expression of proapoptotic genes.49,50 Experi-
mental evidence indicates that inactivation of AKT-FOXO
protein inhibits the survival pathway in the photoreceptors.51
The results obtained with the Western blotting indicate that
melatonin receptors signaling have a significant effect on the P-
AKT/AKT and P-FOXO1/FOXO1 levels (Figs. 3, 4). In C3H/fþ/þ
mice the levels of P-AKTSer473/AKT, P-AKTThr308/AKT, and P-
FOXO1/FOXO1 showed a significant increase during the night
with a peak at night (ZT22, i.e., when melatonin levels are
high, Figs. 3, 4). These results are consistent with previous
study showing a circadian regulation of AKT phosphorylation
on Thr308 that peaked at night in chick retina.52 Indeed, PI3K-
AKT signaling has been shown to contribute to the circadian
phase-dependent modulation of L-type voltage-gated calcium
FIGURE 9. Proposed mechanism to explain the protective action of melatonin on photoreceptors. Left: during the night, once AKT is activated by
melatonin receptors signaling, FOXO1 is phosphorylated. 14-3-3 protein binds to phosphorylated FOXO1 and exported it to the cytoplasm. When
FOXO1 is localized in the cytoplasm, the transcription of proapoptotic genes is suppressed. Right: in the absence of melatonin receptors signaling
AKT is inactive and FOXO1 is localized in the nucleus where it activates the transcription of proapoptotic genes. G, G protein; PIP2,
phosphoinositide-phosphates 2; PIP3, phosphoinositide-phosphates 3; PDK1, phosphoinositide-dependent kinase-1; FasL, Fas ligand.
FIGURE 8. P-FOXO1 is present in rods and in cones. Fluorescence
immunohistochemistry at the level of photoreceptor OS and IS of C3H/
fþ/þmice (3 months old) at ZT22. P-FOXO1 (green) is seen in two
structures (arrow, arrowhead, [A]). Cones are stained with PNA in red
(A’). Merged image reveals P-FOXO1 labeling mostly in cone
(arrowhead), with weaker staining in the surrounding rod OS and IS
(arrow, [A’’]). Scale bar: 20 lm.
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channels (L-VGCCs) in photoreceptors suggesting that PI3K-
AKT signaling serves as a circadian output in the retina (52). P-
AKTSer473/AKT, P-AKTThr308/AKT and P-FOXO1/FOXO1 noc-
turnal peaks were lost in mice lacking melatonin receptors.
Such a result suggests that melatonin receptors signaling are
necessary for the activation of the AKT-FOXO1 pathway at
night in the retina. Although the data obtained with Western
blotting were promising, they did not indicate whether the
changes in the level of P-AKT/AKT and P-FOXO1/FOXO1
observed in C3H/fþ/þ was occurring in the photoreceptors or
in other parts of the retina. To address this question we
decided to investigate the expression of P-AKT and P-FOXO1 in
the retina using immunocytochemistry (Figs. 5–8). Consistent
with previous reports.51,53,54 we localized P-AKT and P-FOXO1
within photoreceptors (rods and cones) and GCL. Moreover,
the pattern of AKT and FOXO1 phosphorylation in the
photoreceptors is affected by removal of melatonin receptors
signaling (Figs. 5, 7) since no differences in the levels were
observed in mice lacking melatonin receptors (Figs. 5, 7). Our
data suggested that the melatonin activation of AKT-FOXO1
pathway at night may be important for the rod and cone
survival during aging.
In conclusion, we believe that melatonin signaling via MT1/
MT2 heteromers protects photoreceptors during aging and we
propose the following working model to explain the protective
action of melatonin on the photoreceptors. In photoreceptors,
nocturnal melatonin binds to MT1/MT2 heteromers to elicit the
recruitment of PI3K to the plasma membrane. The catalytic
subunit of PI3K generates the phosphoinositide-phosphates
PIP2 and PIP3, which, in turn, phosphorylate the phospho-
inositide-dependent kinase-1 (PDK1). Phosphoinositide-depen-
dent kinase-1 activates AKT at Thr308, but AKT also can be
phosphorylated at Ser473 by a PDK1 independent mecha-
nism.49,55 Once AKT is activated, FOXOs are phosphorylated;
14-3-3 protein binds to phosphorylated FOXO to export it to
the cytoplasm. This leads to the suppression of proapoptotic
genes transcription56 (Fig. 9).
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